- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:46 | AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast Cancer | ||
| 17:46 | How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program | ||
| 16:46 | Navigating 2025: Three Key Trends Shaping the Future of Pharma | ||
| 15:02 | Healthcare's Cybersecurity Crisis: Why Today's Defenses Are Failing Against Evolving Threats | ||
| So | Transforming Our Collective Approach to Alzheimer's Disease Care Begins with Early and Accurate Diagnosis | ||
| So | Zero-Sum Game: The Current Healthcare System Is Reaching a Breaking Point | ||
| Fr | FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer | ||
| Fr | Amazon Adds Teladoc Health to Health Benefits Program | ||
| Fr | What's In Store for Hospital M&A in 2025? | ||
| Fr | Late to APP Reporting? Untangle Your ACO's Optimal Method | ||
| Fr | Precision Medicine: Becoming More Real With AI? | ||
| Fr | Join the Healthcare Innovation Conversation at MedCity INVEST | ||
| Fr | A Checklist to Help Healthcare Practices Thrive | ||
| Fr | Galapagos CEO Tells JPM Audience the Rationale for Planned Business Separation | ||
| Fr | Meet the Company Developing an At-Home Test to Replace the Pap Smear | ||
| Do | Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines | ||
| Do | Form Health Unveils New Program to Prevent the Transition from Overweight to Obesity | ||
| Do | From Paper Charts to AI Scribes: The EHR Revolution | ||
| Do | The Near-Term Future of AI in Health Care | ||
| Do | Providence Spun Out Its VC Arm So It Can Partner with Other Health Systems | ||
| Do | Healthcare Leaders Support FTC's Second Report on PBMs, While PBMs Criticize Findings | ||
| Mi | Tech-driven Heart Care Key to Cardiology Desert Crisis | ||
| Mi | Is 'Big Data' the Cure-all for U.S. Healthcare? | ||
| Mi | GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025 | ||
| Mi | At JPM, Eli Lilly's CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
